A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis

por Weisel, Kathy, Scott, Nicola, Berger, Scott, Wang, Susanne, Brown, Kurt, Powell, Marcy, Broer, Matthijs, Watts, Clarissa, Tompson, Debra J, Burriss, Susan W, Hawkins, Simon, Abbott-Banner, Kathy, Tak, Paul Peter
Publicado 2021